15 Dec Predicting the clinical trials of the future: Top 4 trends to watch
Predictions for how clinical trials will evolve to better serve patients in 2023 and beyond....
News
14 Dec Clinical trial trends in 2022
A strong shift to decentralized clinical trials, regulatory changes, and an increased focus on diversity were among the main industry talking points in 2022....
13 Dec Progress toward an eventual HIV vaccine
The promising performance of an experimental HIV vaccine may lead to an effective vaccine strategy for HIV and AIDS....
13 Dec Moderna’s mRNA cancer vaccine shows promise in preliminary study
A customized Moderna Inc. vaccine combined with a Merck & Co. cancer drug helped ward off the recurrence of the skin cancer melanoma after surgery in patients in a mid-stage clinical trial, the companies said....
12 Dec Team Spotlight: Tina Graber
Tina Graber discusses her career path and current role as Operations Manager for the regulatory service line within the UW Clinical Research Office (CRO)....
12 Dec The couple that’s empowering communities of color to participate in Parkinson’s Disease clinical trials
Disease and Bernard Coley are utilizing Denise's Parkinson's disease diagnosis as a platform to inform communities of color about the importance of engaging in clinical trials....
08 Dec Inclusion of participants with cognitive impairment in clinical trials
As the tolerance bar for excluding clinical trials participants on the grounds of race and sex lowers significantly, exclusion based on cognitive disability still goes on....
08 Dec Is a clinical trial right for your child?
Children who participate in clinical trials can help provide researchers with information adults cannot....
08 Dec Antibody drug boosts survival for type of advanced breast cancer
A relatively new drug is boosting survival rates for women with a specific type of advanced breast cancer who haven't responded to other treatments, according to a pair of clinical trials....
07 Dec UW Recognized as a ‘Center of Excellence’ by the PKD Foundation
UW–Madison was chosen as a Center of Excellence due to its elite level of comprehensive, multi-disciplinary care and access to leading clinical research and new therapies for patients with polycystic kidney disease (PKD)....